Eikon Therapeutics Statistics
NASDAQ: EIKNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
4.74-0.02 (-0.42%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Eikon Therapeutics by the numbers
Eikon Therapeutics has a market capitalization of $256.8 million based on 54.19M shares outstanding. With trailing EPS of $-7.86, Eikon Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.5% below its 50-day average and 52.8% below its 200-day average.
Average daily trading volume is 560.40K shares, or about $2.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EIKN valuation vs. peer median
| Metric | EIKN | Peer median | Difference |
|---|---|---|---|
| Market cap | $256.84M | $256.85M | -0% |
| Avg. volume | 560.40K | 904.32K | -38% |
Peer median across 8 companies: OCGN, SABS, EDIT, AGMB, KYTX, AGEN, LXEO, PLX.
Valuation
- Market cap
- $256.84M
- EPS (TTM)
- $-7.86
- Shares outstanding
- 54.19M
Price and trading
- Previous close
- 4.76
- Open
- 4.85
- Day range
- 4.74 – 5.19
- 52-week range
- 4.72 – 17.40
- Beta
- —
- Volume
- 691.44K
- Average volume
- 560.40K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 256.84M
- Forward Pe
- -0.74
- Eps
- -7.86
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.40
- Week52 Low
- 4.72
- Avg Volume
- 560.40K
- Shares Outstanding
- 54.19M
- Ma50
- 7.02
- Ma200
- 10.05
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -72.76%
- Pct From52w Low
- 0.42%